These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38683753)

  • 41. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy.
    Jacob K S; Ganguly S; Kumar P; Poddar R; Kumar A
    J Biomol Struct Dyn; 2017 May; 35(7):1446-1463. PubMed ID: 27142238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors.
    Reddy KK; Singh SK; Tripathi SK; Selvaraj C; Suryanarayanan V
    J Recept Signal Transduct Res; 2013 Aug; 33(4):234-43. PubMed ID: 23638723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
    Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
    Lepesheva GI; Waterman MR
    Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
    Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
    J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme.
    Warrilow AG; Hull CM; Parker JE; Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7121-7. PubMed ID: 25224009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimized expression and catalytic properties of a wheat obtusifoliol 14alpha-demethylase (CYP51) expressed in yeast. Complementation of erg11Delta yeast mutants by plant CYP51.
    Cabello-Hurtado F; Taton M; Forthoffer N; Kahn R; Bak S; Rahier A; Werck-Reichhart D
    Eur J Biochem; 1999 Jun; 262(2):435-46. PubMed ID: 10336628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis.
    Bellamine A; Mangla AT; Nes WD; Waterman MR
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8937-42. PubMed ID: 10430874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba.
    Walvekar S; Anwar A; Anwar A; Sridewi N; Khalid M; Yow YY; Khan NA
    Acta Trop; 2020 Nov; 211():105618. PubMed ID: 32628912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against
    Hahn HJ; Escrig JI; Shing B; Debnath A
    Pathogens; 2020 Aug; 9(9):. PubMed ID: 32825652
    [No Abstract]   [Full Text] [Related]  

  • 51. Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs.
    Hargrove TY; Wawrzak Z; Lamb DC; Guengerich FP; Lepesheva GI
    J Biol Chem; 2015 Sep; 290(39):23916-34. PubMed ID: 26269599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Docking Evaluation of Imidazole Analogues as Potent Candida albicans 14α-Demethylase Inhibitors.
    Rani N; Kumar P; Singh R; Sharma A
    Curr Comput Aided Drug Des; 2015; 11(1):8-20. PubMed ID: 26081558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photochemotherapeutic strategy against Acanthamoeba infections.
    Aqeel Y; Siddiqui R; Anwar A; Shah MR; Khoja S; Khan NA
    Antimicrob Agents Chemother; 2015; 59(6):3031-41. PubMed ID: 25753633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyridylethanol(phenylethyl)amines are non-azole, highly selective Candida albicans sterol 14α-demethylase inhibitors.
    Ogris I; Zelenko U; Sosič I; Gobec M; Skubic C; Ivanov M; Soković M; Kocjan D; Rozman D; Golič Grdadolnik S
    Bioorg Chem; 2021 Jan; 106():104472. PubMed ID: 33261849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against
    Marin V; Iturra A; Opazo A; Schmidt B; Heydenreich M; Ortiz L; Jiménez VA; Paz C
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722158
    [No Abstract]   [Full Text] [Related]  

  • 56. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional importance for developmental regulation of sterol biosynthesis in Acanthamoeba castellanii.
    Zhou W; Warrilow AGS; Thomas CD; Ramos E; Parker JE; Price CL; Vanderloop BH; Fisher PM; Loftis MD; Kelly DE; Kelly SL; Nes WD
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1164-1178. PubMed ID: 30044954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens.
    Becher R; Wirsel SG
    Appl Microbiol Biotechnol; 2012 Aug; 95(4):825-40. PubMed ID: 22684327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors.
    An Y; Liu W; Xie H; Fan H; Han J; Sun B
    Eur J Med Chem; 2022 Jan; 227():113950. PubMed ID: 34731761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of obtusifoliol and analogues as CYP51 substrates.
    Churchman LR; Salisbury LJ; De Voss JJ
    Org Biomol Chem; 2022 Sep; 20(36):7316-7324. PubMed ID: 36069327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.